Related Experiment Video
Updated: Jul 11, 2026
05:41
Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions
Published on: February 9, 2024
Impaired iodide organification in autonomous thyroid nodules
Rodrigo Moreno-Reyes1, Bich-Ngoc-Thanh Tang, Alain Seret
1Department of Nuclear Medicine, Hopital Erasme, Université Libre de Bruxelles, route de Lennik 808, 1070 Brussels, Belgium. rmorenor@ulb.ac.be
The Journal of Clinical Endocrinology and Metabolism
|October 11, 2007
Summary
Most autonomous thyroid nodules (ATN) show impaired iodide organification. This study investigated iodide organification efficiency in ATN and its relation to thyroid status, finding impaired function in the majority of patients.
Area of Science:
- Endocrinology
- Nuclear Medicine
- Thyroidology
Background:
- Autonomous thyroid nodules (ATN) have unpredictable clinical progression.
- Thyrotoxicosis can occur at various nodule sizes.
- In vitro studies suggest reduced hydrogen peroxide production in ATN, pointing to impaired iodide organification.
Purpose of the Study:
- To assess iodide organification efficiency in patients with ATN.
- To explore the relationship between iodide organification and thyroid status in these patients.
Main Methods:
- Study included 46 patients with a single ATN identified via 123I thyroid scan.
- Conducted biological evaluation and iodine perchlorate (I-ClO4) discharge tests.
- Data collected from an academic hospital setting.
Main Results:
- A positive I-ClO4 discharge test (indicating impaired organification) was observed in 61% of patients (mean discharge 42%).
- A negative discharge test was seen in 39% (mean discharge 5%).
- In patients with a negative discharge test, serum free T3 and free T4 levels correlated with 123I uptake, but hyperthyroidism severity did not differ between groups.
Conclusions:
- Intranodular iodide organification is impaired in most patients with ATN.
- Further research is needed to determine if organification capability predicts the risk of developing overt hyperthyroidism in ATN patients.
Related Concept Videos
01:27Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:23Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:23The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...